Medicine Details
Brand name – Velpanat
Generic name – Sofosbuvir/Velpatasvir
Manufacturer – Natco Pharma Ltd
Salt composition – Sofosbuvir and Velpatasvir
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 400mg + 100mg
Packaging – Bottle of 28 tablets
Gender – Unisex
Active ingredient – Sofosbuvir/Velpatasvir
Prescription required – Yes
Indication – Used in the treatment of chronic hepatitis C virus (HCV) infection
Description
Velpanat is a combination of two antivirals. It is used in the treatment of chronic hepatitis C virus infection. This combination of Sofosbuvir and Velpatasvir is known to be the first once-daily single-tablet treatment with pangenotypic activity. Velpanat (Sofosbuvir/Velpatasvir) works to fight against the virus in order to resolve the infection. Velpanat should be taken in the prescribed dose and duration. No alterations or manipulations should be done unless your healthcare provider tells you.
Pharmacodynamics
Velpanat is a combination of velpatasvir & sofosbuvir. Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor and Velpatasvir is an NS5A replication complex inhibitor. Sofosbuvir is used in the treatment of genotype 1, 2, 3, and 4 HCV infection with different medicines, wherein duration depends on the HCV genotype. Velpatasvir is a novel NS5A inhibitor. It has potent in vitro anti-HCV activity across all genotypes at the picomolar level. The effect of Sofosbuvir (Velpanat) 400 mg (recommended dosage) and 1200 mg (three times the recommended dosage) on QTc interval was calculated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Sofosbuvir (Velpanat) does not prolong QTc to any clinically relevant extent, at a dose (three times the recommended dose). The effect of Velpatasvir (Velpanat) 500 mg (five times the recommended dosage) was calculated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Velpatasvir (Velpanat) does not prolong QTc interval to any clinically relevant extent, at a dose five times the recommended dose.
Ingredients
The active ingredient of Velpanat is Sofosbuvir/Velpatasvir.
Usage Of Medicine
Velpanat (Sofosbuvir/Velpatasvir) is used in the treatment of chronic hepatitis C virus (HCV) infection. Hepatitis C is an infection in the liver, which is caused by Hepatitis C Virus. Velpanat (Sofosbuvir/Velpatasvir) helps to control this infection.
Alternate Brands
- Velpaclear Tablet
- Sofocure-v Tablet
- Sovihep V Tablet
- Velasof Tablet
- Resof total tablet


